Cytokine IL-1β, one of the signature cytokines of RA and a target of a commonly used RA therapeutic [19,20], is found shortly after arthritis induction and can be reduced upon dexamethasone treatment (Figure 2B, *p < 0.05). This evidence concerns the gene IL1B and rheumatoid arthritis.